Literature DB >> 2817169

To tell or not to tell: the ethical dilemmas of HIV test notification in epidemiologic research.

A L Avins1, B Lo.   

Abstract

Epidemiologic studies involving HIV (human immunodeficiency virus) antibody testing create ethical dilemmas, particularly about notifying asymptomatic seropositive subjects. Four study designs address this problem: mandatory notification, optional notification, anonymous testing, and blind testing. No single design consistently optimizes the trade-off between valid and ethical research. Each strategy differs substantially from the others in its effect on response rates, bias, ability to perform longitudinal studies, numbers of subjects who learn their test results, and the number of subjects counseled about HIV risk reduction. Both local institutional review boards and potential subjects of study (and their sexual partners) should participate in decisions regarding the conduct of sensitive AIDS (acquired immunodeficiency syndrome) research.

Entities:  

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health; Professional Patient Relationship; Public Health Service

Mesh:

Year:  1989        PMID: 2817169      PMCID: PMC1349811          DOI: 10.2105/ajph.79.11.1544

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  25 in total

1.  Guidelines for confidentiality in research on AIDS.

Authors:  Ronald Bayer; Carol Levine; Thomas H Murray
Journal:  IRB       Date:  1984 Nov-Dec

2.  ABC of AIDS. Being HIV antibody positive.

Authors:  J Grimshaw
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

3.  A frustrating glimpse of the true AIDS epidemic.

Authors:  W Booth
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

4.  HIV antibody screening. An ethical framework for evaluating proposed programs.

Authors:  R Bayer; C Levine; S M Wolf
Journal:  JAMA       Date:  1986-10-03       Impact factor: 56.272

5.  AIDS and the limits of confidentiality: the physician's duty to warn contacts of seropositive individuals.

Authors:  T A Brennan
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

6.  The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report.

Authors:  N Levy; J R Carlson; S Hinrichs; N Lerche; M Schenker; M B Gardner
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

7.  Behavioral consequences of AIDS antibody testing among gay men.

Authors:  T J Coates; S F Morin; L McKusick
Journal:  JAMA       Date:  1987-10-09       Impact factor: 56.272

Review 8.  AIDS screening, confidentiality, and the duty to warn.

Authors:  L Gostin; W J Curran
Journal:  Am J Public Health       Date:  1987-03       Impact factor: 9.308

9.  The HIV antibody test: why gay and bisexual men want or do not want to know their results.

Authors:  D W Lyter; R O Valdiserri; L A Kingsley; W P Amoroso; C R Rinaldo
Journal:  Public Health Rep       Date:  1987 Sep-Oct       Impact factor: 2.792

10.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

View more
  7 in total

Review 1.  Ethical problems raised by anti-HIV vaccination.

Authors:  P Enel; J Charrel; M P Larher; D Reviron; C Manuel; J L San Marco
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

Review 2.  AIDS, a social dilemma: detection of seropositives.

Authors:  P Enel; C Manuel; J Charrel; M P Larher; D Reviron; J L San Marco
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

3.  Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.

Authors:  Claustre Pont-Sunyer; Susan Bressman; Deborah Raymond; Amanda Glickman; Eduardo Tolosa; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2015-05-07       Impact factor: 10.338

4.  The outreach-assisted model of partner notification with IDUs.

Authors:  J A Levy; S E Fox
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

5.  Estimated burden of diabetes mellitus in Manitoba according to health insurance claims: a pilot study.

Authors:  T K Young; N P Roos; K M Hammerstrand
Journal:  CMAJ       Date:  1991-02-01       Impact factor: 8.262

6.  A genetic researcher's devil's dilemma: Warn relatives about their genetic risk or respect confidentiality agreements with research participants?

Authors:  Els L M Maeckelberghe; M Corrette Ploem; Imke Christiaans; Lieke M van den Heuvel
Journal:  BMC Med Ethics       Date:  2021-11-23       Impact factor: 2.652

7.  The ethics of unlinked anonymous testing of blood: views from in-depth interviews with key informants in four countries.

Authors:  Anthony S Kessel; Jessica Datta; Kaye Wellings; Sarah Perman
Journal:  BMJ Open       Date:  2012-12-20       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.